Licence summary · commercial-use boundaries for RxAtlas

This is a plain-English summary for the US Drug Database, NDC API and Download. The binding text is the Terms, the checkout/order terms, and the per-source licence records on Sources & licences.

Licence posture is tied to the commercial data contract: paid SKUs come from PRICING_SKUS, export formats from SNAPSHOT_FORMATS, source obligations from sourceCatalog, and buyer caveats from websiteContent.complianceCaveats.

What paid access grants

Paid access is designed for one organisation to evaluate, load, query, and use the dataset in internal business systems. Each delivered snapshot is a versioned artifact; the API and MCP surfaces are live access paths over the same schema and provenance model.

Load delivered snapshot files into a warehouse, lake, local database, or internal application.
Query the REST API or MCP server for internal workflows covered by the purchased tier.
Share results with employees and contractors acting for your organisation.
Use provenance, source URLs, and licence fields for internal audit, procurement, and compliance review.
Publish derived analysis when it does not expose row-level data or a substantial extract of the dataset.

Snapshot tiers

The licence summary follows the checkout SKUs so pricing and usage rights stay aligned.

Snapshot

$499 one-time

Snapshot + API

$1,499 / 12 months

Enterprise

Snapshot exports are published in the formats below. Buyer downloads are delivered through the authenticated portal, not as public file URLs.

JSON snapshot
application/json
CSV snapshot
text/csv
SQLite snapshot
application/x-sqlite3

Sample scope

The public evaluation sample currently contains 150 rows (92.9 KB zip · 25 JSON fields · 13 flat columns). It uses the same schema, source metadata, and provenance posture as the paid snapshot, but it is an evaluation artifact and not a production licence.

Restrictions

Unless the order form or Enterprise agreement says otherwise, the standard package is licensed for internal use only.

Do not resell, redistribute, sublicense, lease, or publish the dataset or a substantial extract as a dataset.
Do not expose row-level records through a customer-facing product or public query interface.
Do not remove provenance, source URLs, attribution notices, or licence fields from operational copies.
Do not share API tokens outside your organisation or work around rate limits.
Do not treat the dataset as professional, legal, medical, safety, financial, or regulatory advice.

Source-specific terms & flow-down

The source registry currently lists 13 commercial-use cleared sources. The downloadable snapshot and API include only records cleared for the paid release.

Commercial-use cleared

13 sources

Sources cleared in the manifest for commercial dataset redistribution and buyer-facing exports.

source	licence	export
CMS — State Drug Utilization Data 2025	Public Domain Mark 1.0	commercial-use cleared
DailyMed — Structured Product Labels (U.S. National Library of Medicine)	US Public Domain (NLM)	commercial-use cleared
openFDA — Drugs@FDA application lifecycle	Public Domain and CC0	commercial-use cleared
FDA — Inactive Ingredients Database	US Public Domain (CAS Registry Numbers excluded)	commercial-use cleared
FDA Orange Book — Approved Drug Products with Therapeutic Equivalence Evaluations	US Public Domain	commercial-use cleared
FDA — Postmarketing Requirements and Commitments	US Public Domain	commercial-use cleared
FDA — Risk Evaluation and Mitigation Strategies	US Public Domain	commercial-use cleared
NADAC — National Average Drug Acquisition Cost (CMS / Medicaid)	US Public Domain	commercial-use cleared
openFDA — Drug Shortages	CC0 1.0	commercial-use cleared
openFDA — Drug Enforcement (recalls)	CC0 1.0	commercial-use cleared
openFDA — National Drug Code Directory	CC0 1.0	commercial-use cleared
openFDA — Unique Ingredient Identifiers	CC0 1.0	commercial-use cleared
RxNorm — normalized clinical drug names (U.S. National Library of Medicine)	RxNorm (RXNORM/MTHSPL subset, redistributable)	commercial-use cleared

The full source register, homepages, jurisdictions, and licence notes live on Sources & licences. Preserve source codes so JSON-LD DataCatalog entries and docs anchors resolve to the same records.

Attribution

Keep source and provenance metadata attached to operational copies. When publishing permitted derived analysis, include a dataset-level credit and any upstream attribution required by the cited source licences.

attribution exampletext

US Drug Database, NDC API and Download: RxAtlas.
Underlying sources and per-field provenance: RxAtlas / docs / sources.

AI training

Standard snapshot SKUs do not grant a separate right to train, fine-tune, distil, or build embedding corpora from the dataset. If a buyer needs AI-training rights, model-distribution rights, or a share-alike-free source variant, handle that as an Enterprise scope.

Warranty posture

These are provenance-first reference datasets, not official source authority services. The Terms control warranty, limitation of liability, and acceptable-use language. The practical buyer caveats for this dataset are:

RxAtlas is reference data, not medical advice, prescribing advice or reimbursement advice.
Buyers remain responsible for validating source terms and regulated use in their own workflow.

Enterprise rights

Redistribution, customer-facing embed, AI-training, custom refresh SLAs, indemnity, escrow, residency, and master-agreement terms belong in an Enterprise order form. Start from pricing or email data@apex-db.org.